Vaughan DE - Search Results

1

An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validation.

Coffey CS, Hebert PR, Ritchie MD, Krumholz HM, Gaziano JM, Ridker PM, Brown NJ, Vaughan DE, Moore JH. Coffey CS, et al. Among authors: vaughan de. BMC Bioinformatics. 2004 Apr 30;5:49. doi: 10.1186/1471-2105-5-49. BMC Bioinformatics. 2004. PMID: 15119966 Free PMC article.

2

Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men.

Ridker PM, Baker MT, Hennekens CH, Stampfer MJ, Vaughan DE. Ridker PM, et al. Among authors: vaughan de. Arterioscler Thromb Vasc Biol. 1997 Sep;17(9):1687-90. Arterioscler Thromb Vasc Biol. 1997. PMID: 9327764

3

A population-based study in Ghana to investigate inter-individual variation in plasma t-PA and PAI-1.

Williams SM, Stocki S, Jiang L, Brew K, Gordon S, Vaughan DE, Brown NJ, Poku KA, Moore JH. Williams SM, et al. Among authors: vaughan de. Ethn Dis. 2007 Summer;17(3):492-7. Ethn Dis. 2007. PMID: 17985503

4

A comparison of combinatorial partitioning and linear regression for the detection of epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms on plasma PAI-1 levels.

Moore JH, Lamb JM, Brown NJ, Vaughan DE. Moore JH, et al. Among authors: vaughan de. Clin Genet. 2002 Jul;62(1):74-9. doi: 10.1034/j.1399-0004.2002.620110.x. Clin Genet. 2002. PMID: 12123491

5

Hemostatic factors and the risk of myocardial infarction.

Ridker PM, Vaughan DE. Ridker PM, et al. Among authors: vaughan de. N Engl J Med. 1995 Aug 10;333(6):389; author reply 389-90. N Engl J Med. 1995. PMID: 7609765 No abstract available.

6

The renin-angiotensin-aldosterone system and fibrinolysis in progressive renal disease.

Brown NJ, Vaughan DE, Fogo AB. Brown NJ, et al. Among authors: vaughan de. Semin Nephrol. 2002 Sep;22(5):399-406. doi: 10.1053/snep.2002.34725. Semin Nephrol. 2002. PMID: 12224047 Review.

7

Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition.

Brown NJ, Muldowney JA 3rd, Vaughan DE. Brown NJ, et al. Among authors: vaughan de. Hypertension. 2006 Mar;47(3):441-8. doi: 10.1161/01.HYP.0000202478.79587.1a. Epub 2006 Jan 23. Hypertension. 2006. PMID: 16432054 Clinical Trial.

8

The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels.

Asselbergs FW, Williams SM, Hebert PR, Coffey CS, Hillege HL, Navis G, Vaughan DE, van Gilst WH, Moore JH. Asselbergs FW, et al. Among authors: vaughan de. Thromb Haemost. 2006 Oct;96(4):471-7. Thromb Haemost. 2006. PMID: 17003924

9

Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels.

Asselbergs FW, Williams SM, Hebert PR, Coffey CS, Hillege HL, Navis G, Vaughan DE, van Gilst WH, Moore JH. Asselbergs FW, et al. Among authors: vaughan de. Genomics. 2007 Mar;89(3):362-9. doi: 10.1016/j.ygeno.2006.11.004. Epub 2007 Jan 5. Genomics. 2007. PMID: 17207964 Free PMC article.

10

Epistatic interactions in genetic regulation of t-PA and PAI-1 levels in a Ghanaian population.

Penrod NM, Poku KA, Vaughan DE, Asselbergs FW, Brown NJ, Moore JH, Williams SM. Penrod NM, et al. Among authors: vaughan de. PLoS One. 2011 Jan 31;6(1):e16639. doi: 10.1371/journal.pone.0016639. PLoS One. 2011. PMID: 21304999 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters